Cardinal Health
CAH
232.16
-1.28
-0.55%
Cardinal Health
US · CAH
#429 by market cap
Listed 1970
232.16
-1.28
-0.55%
Live - 5344 symbols - heartbeat 12s ago
· 2026-10-08 04:00
Pre-market
232.16
0.00%
After-hours
232.90
+0.32%
- Market cap
- 53.76B
- P/E (TTM)i
- 32.11
- P/Bi
- -18.65
- EPSi
- 7.23
- Div yieldi
- 0.88%
- 52W posi
- 76%
Reader sentiment
Are you bullish or bearish on CAH?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 14 analysts
Buy
Avg price target
270.00 +16.3%
Price target rangecurrent 232.16
Low250.00
Avg270.00
High292.00
Buy 86%
Hold 14%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-09 | Wells Fargo | -- | BUY | 277.00 |
| 2026-08-19 | RBC Capital | -- | BUY | 276.00 |
| 2026-08-18 | Barclays | -- | BUY | 275.00 |
| 2026-08-17 | J.P. Morgan | -- | HOLD | 260.00 |
| 2026-08-13 | TD Cowen | -- | BUY | 280.00 |
| 2026-08-13 | Mizuho Securities | -- | BUY | 250.00 |
| 2026-08-13 | Deutsche Bank | -- | HOLD | 261.00 |
| 2026-08-13 | J.P. Morgan | -- | HOLD | 260.00 |
| 2026-08-12 | TD Cowen | -- | BUY | 280.00 |
| 2026-08-12 | Wells Fargo | -- | BUY | 277.00 |
| 2026-08-12 | Morgan Stanley | -- | BUY | 255.00 |
| 2026-08-12 | Evercore | -- | BUY | 270.00 |
| 2026-08-12 | Citi | -- | BUY | 280.00 |
| 2026-08-12 | Barclays | -- | BUY | 275.00 |
| 2026-08-11 | William Blair | -- | BUY | -- |
| 2026-08-11 | Leerink Partners | -- | BUY | 292.00 |
| 2026-08-03 | Deutsche Bank | -- | HOLD | -- |
| 2026-07-28 | Mizuho Securities | -- | BUY | 240.00 |
| 2026-07-24 | Citi | -- | BUY | 265.00 |
| 2026-07-23 | Mizuho Securities | -- | BUY | 240.00 |
| 2026-07-20 | UBS | -- | BUY | 274.00 |
| 2026-07-20 | BofA Securities | -- | BUY | 260.00 |
| 2026-07-09 | TD Cowen | -- | BUY | 275.00 |
| 2026-07-02 | BofA Securities | -- | BUY | 260.00 |
| 2026-06-10 | Barclays | -- | BUY | 258.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
B
Momentum strategy signal
Buy
Analyst consensus
Buy
All 3 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: Citi moved from Hold to Buy on 2026-01-09.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-01-09 | Citi | HOLD → BUY | 244.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q4 | 2026-08-11 | -- | ±6.09% | +1.30% (in line) |
| 2026/Q3 | 2026-04-30 | -- | ±6.45% | -4.90% (in line) |
| 2026/Q2 | 2026-02-05 | -- | ±4.68% | +9.83% (beat) |
| 2026/Q1 | 2025-10-30 | -- | ±4.16% | +15.43% (beat) |
| 2025/Q4 | 2025-08-12 | -- | ±4.52% | -7.21% (beat) |
| 2025/Q3 | 2025-05-01 | -- | ±5.46% | +3.00% (in line) |
| 2025/Q2 | 2025-01-30 | -- | ±4.50% | +0.39% (in line) |
| 2025/Q1 | 2024-11-01 | -- | ±6.04% | +7.01% (beat) |
| 2024/Q4 | 2024-08-14 | -- | ±5.43% | +3.68% (in line) |
| 2024/Q3 | 2024-05-02 | -- | ±3.86% | +0.79% (in line) |
| 2024/Q2 | 2024-02-01 | -- | ±4.19% | -3.75% (in line) |
| 2024/Q1 | 2023-11-03 | -- | ±5.01% | +6.86% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 04:00:12 · For reference only, not investment advice and not tailored to your situation.